SMAD2 and myelodysplastic syndrome: Smad-dependent BMP signaling affects the production of SDF-1 in the BMME, reducing HSPC homing, engraftment, and mobilization [7], while Smad2 inhibition stimulates hematopoiesis from primary MDS progenitors [6].